Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Oguz Altunok
Observed names:
Altunok, Oğuz,
O. Altunok,
Oğuz Altunok
Institutions:
Bakırköy Dr.Sadi Konuk Eğitim ve Araştırma Hastanesi,
Sağlık Bilimleri Üniversitesi
Observed institutions:
İstanbul Eğitim ve Araştırma Hastanesi,
Bakırköy Dr.Sadi Konuk Eğitim ve Araştırma Hastanesi,
Sağlık Bilimleri Üniversitesi
ORCID:
0000-0002-7278-1307
Observed ORCID:
0000-0002-7278-1307
OpenAlex ID:
A5126249801
A new parameter in COVID-19 pandemic: initial lactate dehydrogenase (LDH)/Lymphocyte ratio for diagnosis and mortality
2020
·
Istemi Serin
, Nagehan Didem Sari
, et al.
·
Journal of Infection and Public Health
·
27
PDF
Immune-related adverse events as predictors of pathological complete response in early-stage triple-negative breast cancer treated with pembrolizumab
2026
·
Ali Kaan Güren
, Nazım Can Demircan
, et al.
·
Immunotherapy
·
4
Real-world outcomes of trastuzumab deruxtecan in patients with HER2+ metastatic breast cancer: Turkish oncology group multicenter study
2026
·
Taha Koray Sahin
, Fatih Kemik
, et al.
·
Therapeutic Advances in Medical Oncology
·
1
Pb2234: Effect of Hydroxyurea on Inflammatory Markers in Patients With Bcr-abl Negative Myeloproliferative Diseases
2023
·
Oguz Altunok
, Istemi Serin
, et al.
·
HemaSphere
·
1
Prognostic value of CT-measured baseline tumor volume in nivolumab-treated metastatic renal cell carcinoma
2026
·
Seher Yıldız Tacar
, Deniz Tural
, et al.
·
Tumori Journal
Author response for "Prognostic Value of CT Measured Baseline Tumor Volume in Nivolumab Treated Metastatic Renal Cell Carcinoma"
2026
·
Seher Yıldız Tacar
, Deniz Tural
, et al.
·
Publons reviews and discussion
Association Between ABO Blood Group and Survival in Early-Stage Colon Cancer: A Single-Center Retrospective Cohort Analysis
2026
·
Mesut Yılmaz
, Oğuz Altunok
, et al.
·
Cancer Management and Research
PDF
Antibody–drug conjugate sequencing in HER2-positive metastatic breast cancer: Real-world outcomes of trastuzumab deruxtecan with and without prior T-DM1 exposure
2026
·
Fatih Kemik
, Taha Koray Şahin
, et al.
·
The Breast
Abstract PS5-02-08: Impact of Prior T-DM1 Exposure on the Efficacy of Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer
2026
·
F. Kemik
, T. K. Sahin
, et al.
·
Clinical Cancer Research
Abstract PS5-05-14: Real-world outcomes of trastuzumab deruxtecan (T-DXd) in patients with HER2+ metastatic breast cancer: Turkish oncology group multicenter study
2026
·
T. Sahin
, F. Kemik
, et al.
·
Clinical Cancer Research
Her2 Pozitif Metastatik Meme Kanserli Hastalarda Trastuzumab Deruxtecan’in Gerçek Yaşam Verileri: Türk Onkoloji Grubu Çok Merkezli Çalişmasi
2025
·
Oruç, Ahmet
, Şahin, Taha Koray
, et al.
·
Kocaeli Üniversitesi - AVESİS
A Case of Diffuse Large B Cell Lymphoma with Unusual Extranodal Breast, Brain Involvement and Autoimmune Hemolytic Anemia: Clinical and Radiological Presentations
2023
·
İstemi Serin
, Yuksel Erdal
, et al.
·
Acta Oncologica Turcica
PDF
Show more works
View as search
Works count:
12
Citation count:
33
H-index:
2
I10-index:
1
Year
Topic
Type